Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

Phase 1

Completed

• Conditions: Bronchiolitis

• Registration Number: NCT00261937
• Lead Sponsor: Bnai Zion Medical Center

Brief Summary

We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.

Detailed Description

Not available

Study Timeline

• Status Verified: 2005-12
• Study Start: 2005-12
• Study First Submitted: 2005-12-05
• Study First Submitted QC: 2005-12-05
• Study First Posted: 2005-12-06
• Study Completion: 2006-04
• Last Update Submitted: 2013-02-05
• Last Update Posted: 2013-02-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Age: 0-12 months.
• Infants who are otherwise healthy
• Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
• Parents signed a written informed consent.

Exclusion Criteria

• • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Clinical respiratory effects

Secondary Outcome Measures

Name	Time	Method
1. The duration of hospitalization
2. Time weaned off oxygen
3. Time to full enteral feeding

Trial Locations

Locations (1)

Bnai Zion Medical Center and Naharia Galilli Medical Center; 🇮🇱 Haifa, Israel